CVMP assessment report, Panacur AquaSol (EMEA/V/C/2008), common name fenbendazole (2011)

Government Record · European Medicines Agency, Committee for Medicinal Products for Veterinary Use · December 8, 2011

European Medicines Agency et al., 2011-12-08: EMA's assessment report for Panacur AquaSol, a 20% fenbendazole oral suspension for pigs in drinking water, filed by Intervet International BV and authorised through the EU centralised procedure (EMEA/V/C/2008). It shows the same Panacur brand and the Intervet entity holding an EU veterinary marketing authorisation.

Panacur AquaSol contains fenbendazole as the active substance and is presented in packs/containers of 1 bottle in three different sizes 125 ml, 1 litre and 4 litres. It is indicated for the treatment and control of gastro-intestinal nematodes in pigs.

p.2 (Introduction)

European Medicines Agency et al., 2011-12-08: EMA's assessment report for Panacur AquaSol, a 20% fenbendazole oral suspension for pigs in drinking water, filed by Intervet International BV and authorised through the EU centralised procedure (EMEA/V/C/2008). It shows the same Panacur brand and the Intervet entity holding an EU veterinary marketing authorisation. EU marketing authorisation assessment report (veterinary), 2011. Applicant and future MA holder: Intervet International BV, Boxmeer, Netherlands – the Akzo Nobel/Schering-Plough/Merck animal-health entity (see C4). Target species pigs at authorisation; the product was later extended (see the variation reports on the same EMA page). This is a veterinary authorisation, not a human one. Excerpt replaced with one continuous passage from the Introduction (an earlier draft spliced two sentences and was corrected). Study type: regulatory record.